{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:06:49Z","timestamp":1765728409554,"version":"3.38.0"},"reference-count":20,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.nephro.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T04:55:40Z","timestamp":1310187340000},"page":"35-40","source":"Crossref","is-referenced-by-count":6,"title":["Les formes cliniques et biologiques de l\u2019hyperparathyro\u00efdie secondaire en dialyse"],"prefix":"10.1684","volume":"8","author":[{"given":"Guillaume","family":"Jean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Souberbielle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie","family":"Lorriaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brice","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Hurot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Deleaval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Chazot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2011.05.002_bib0005","first-page":"S1","article-title":"Work Group Kdigo clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","author":"Kdigo","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2011.05.002_bib0010","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","article-title":"Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management","volume":"35","author":"Block","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2011.05.002_bib0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000274483","article-title":"Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism","volume":"31","author":"Kumata","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2011.05.002_bib0020","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00302.2004","article-title":"The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism","volume":"288","author":"Rodriguez","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nephro.2011.05.002_bib0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/BF02385267","article-title":"Secondary hyperparathyroidism: pathophysiology, histopathology, and medical and surgical management","volume":"27","author":"Tominaga","year":"1997","journal-title":"Surg Today"},{"key":"10.1016\/j.nephro.2011.05.002_bib0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of ckd patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2011.05.002_bib0035","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","article-title":"Circulating biochemical markers of bone remodeling in uremic patients","volume":"55","author":"Urena","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2011.05.002_bib0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nephro.2010.12.010","article-title":"Calcimimetics: physiology, results of preclinical and clinical studies, and perspectives","volume":"7","author":"Torres","year":"2011","journal-title":"N\u00e9phrologie & Th\u00e9rapeutique"},{"key":"10.1016\/j.nephro.2011.05.002_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nephro.2009.12.004","article-title":"Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with cinacalcet: an efficiency strategy","volume":"6","author":"Jean","year":"2010","journal-title":"N\u00e9phrologie & Th\u00e9rapeutique"},{"key":"10.1016\/j.nephro.2011.05.002_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The optima study: assessing a new cinacalcet (sensipar\/mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2011.05.002_bib0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.ajkd.2007.12.002","article-title":"A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the dialysis clinical outcomes revisited (DCOR) randomized trial using claims data","volume":"51","author":"St Peter","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.nephro.2011.05.002_bib0060","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The advance study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2011.05.002_bib0065","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of cinacalcet therapy to lower cardiovascular events (Evolve): rationale and design overview","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2011.05.002_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"Bone metabolism and disease in chronic kidney disease","volume":"42","author":"Eknoyan","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2011.05.002_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00198-004-1712-4","article-title":"Serum levels of C-terminal telopeptide of type 1\u00a0collagen: a useful new marker of cortical bone loss in hemodialysis patients","volume":"16","author":"Okuno","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.nephro.2011.05.002_bib0080","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2011.05.002_bib0085","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","article-title":"K\/DOQI-recommended intact pth levels do not prevent low-turnover bone disease in hemodialysis patients","volume":"73","author":"Barreto","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2011.05.002_bib0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5414\/CNP68063","article-title":"Twelve months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers","volume":"68","author":"Jean","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2011.05.002_bib0095","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1053\/ajkd.2001.20740","article-title":"Role of phosphorus in the pathogenesis of secondary hyperparathyroidism","volume":"37","author":"Slatopolsky","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2011.05.002_bib0100","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"73","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int Suppl"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972551100109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972551100109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2011.05.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:05:51Z","timestamp":1741187151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S176972551100109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S176972551100109X"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2011.05.002","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}